Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)		9 Months Ended
		Sep. 30, 2018		Sep. 30, 2017
Cash flows from operating activities:
Net income (loss) attributable to common shareholders		$ 22,743,537		$ (2,394,288)
Adjustments to reconcile net income to net cash used in operating activities:
Amortization (accretion) of investments		137,899		191,820
Other-than-temporary impairments		300,000		0
Realized investment gains, net		(12,723,566)		(1,665,920)
Change in fair value of equity securities	[1]	(22,050,489)		0
Unrealized trading (gains) losses included in income		0		111,531
Realized trading (gains) included in income		0		(110,470)
Amortization of cost of insurance acquired		604,549		629,328
Depreciation		814,202		515,132
Net income (loss) attributable to noncontrolling interest		184,565		(63,117)
Charges for mortality and administration of universal life and annuity products		(4,948,332)		(4,982,000)
Interest credited to account balances		3,177,834		3,268,536
Change in accrued investment income		42,511		390,309
Change in reinsurance receivables		91,579		90,361
Change in policy liabilities and accruals		(2,613,125)		(988,645)
Change in income taxes receivable (payable)		2,221,052		(167,359)
Change in other assets and liabilities, net		9,987,926		(1,927,847)
Net cash provided by (used in) operating activities		(2,029,858)		(7,102,629)
Proceeds from investments sold and matured:
Fixed maturities available for sale		54,220,638		17,036,549
Equity securities		843,260		3,401,217
Mortgage loans		4,496,554		860,187
Real estate		12,783,088		6,422,788
Notes receivable		2,559,264		2,035,706
Policy loans		1,423,014		1,481,824
Short-term investments		2,114,000		0
Total proceeds from investments sold and matured		78,439,818		31,238,271
Cost of investments acquired:
Fixed maturities available for sale		(42,955,401)		(11,603,539)
Equity securities		(9,538,853)		(2,471,066)
Mortgage loans		(16,453)		(360,531)
Real estate		(10,113,852)		(2,473,761)
Notes receivable		(4,000,000)		(2,797,853)
Policy loans		(1,244,976)		(1,081,284)
Short-term investments		(7,549,076)		0
Total cost of investments acquired		(75,418,611)		(20,788,034)
Net cash provided by (used in) investing activities		3,021,207		10,450,237
Cash flows from financing activities:
Policyholder contract deposits		3,548,809		3,641,050
Policyholder contract withdrawals		(2,849,310)		(3,733,565)
Proceeds from notes payable/line of credit		0		0
Payments of principal on notes payable/line of credit		0		(1,450,000)
Purchase of treasury stock		(1,217,802)		(396,628)
Issuance of stock		246,757		197,488
Non controlling contributions (distributions) of consolidated subsidiary		(247,592)		(772,754)
Net cash provided by (used in) financing activities		(519,138)		(2,514,409)
Net increase (decrease) in cash and cash equivalents		472,211		833,199
Cash and cash equivalents at beginning of period		25,434,199	[2]	15,156,548
Cash and cash equivalents at end of period		$ 25,906,410		$ 15,989,747

[1] Effective January 1, 2018, the Company adopted ASU No. 2016-01. As a result, equity securities are no longer classified as available-for-sale with unrealized gains and losses recognized in other comprehensive income; rather, all changes in the fair value of equity securities are now recognized in net income. Prior periods have not been restated to conform to the current presentation. See note 2.

[2] Balance sheet audited at December 31, 2017.